Evolent Health Inc. is reportedly exploring a potential sale after receiving acquisition interest, leading to a notable increase in its stock price, which rose by 9.46%. The company is in discussions with several potential bidders, including private equity firms TPG, Clayton, Dubilier & Rice (CD&R), KKR, and Elevance Health. The news has generated significant market attention, contributing to a surge in Evolent's shares. In a related development, TPG and UnitedHealth are also noted as suitors for Surgery Partners, which saw its shares increase by 13% following reports of acquisition interest. The ongoing interest in both Evolent Health and Surgery Partners highlights a trend of consolidation in the healthcare sector.